Option Care Health, Inc.
OPCH
株式のランク
#3633
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
株価
$31.24
時価総額
$4.68B
変化（1日）
0.08%
変化（1年）
10.06%
国
US
取引 Option Care Health, Inc. (OPCH)
カテゴリー
Healthcare
Option Care Health, Inc.（OPCH）の利益
Jun 2026 時点の利益 TTM: $285.47M
Option Care Health, Inc. の最新の財務報告によると、同社の現在の利益は $285.47M です。2023 年には $358.74M の利益を上げ、これは 2022 年の利益 $205.77M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Option Care Health, Inc. の利益の推移（2000 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $285.47M | 0.66% |
| 2024 | $283.60M | -20.95% |
| 2023 | $358.74M | 74.34% |
| 2022 | $205.77M | 76.63% |
| 2021 | $116.49M | -2,321.90% |
| 2020 | $-5.24M | -93.29% |
| 2019 | $-78.19M | 791.81% |
| 2018 | $-8.77M | -87.00% |
| 2017 | $-67.43M | 97.42% |
| 2016 | $-34.16M | -89.53% |
| 2015 | $-326.35M | 135.25% |
| 2014 | $-138.73M | 97.11% |
| 2013 | $-70.38M | 262.94% |
| 2012 | $-19.39M | -176,390.91% |
| 2011 | $11.00K | -100.06% |
| 2010 | $-18.98M | -240.08% |
| 2009 | $13.55M | -115.71% |
| 2008 | $-86.23M | -1,645.03% |
| 2007 | $5.58M | -128.98% |
| 2006 | $-19.26M | -34.92% |
| 2005 | $-29.60M | -357.66% |
| 2004 | $11.49M | -24.52% |
| 2003 | $15.22M | -34.85% |
| 2002 | $23.36M | 54.33% |
| 2001 | $15.13M | -983.48% |
| 2000 | $-1.71M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $9.87B | 3,357.77% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 1,253.89% |
US
|
|
| $687.82M | 140.94% |
SA
|
|
| $1.25B | 336.72% |
BR
|
